Per Wikstrom
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Specific NOX4 Inhibition Preserves Mitochondrial Function and Dampens Kidney Dysfunction Following Ischemia-Reperfusion-Induced Kidney Injury.
Journal: Antioxidants (Basel, Switzerland)
Published: March 04, 2024
Investigation of the Effects of a Novel NOX2 Inhibitor, GLX7013170, against Glutamate Excitotoxicity and Diabetes Insults in the Retina.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 09, 2024
The selective NOX4 inhibitor GLX7013159 decreases blood glucose concentrations and human beta-cell apoptotic rates in diabetic NMRI nu/nu mice transplanted with human islets.
Journal: Free radical research
Published: November 16, 2023
Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy.
Journal: Diabetes
Published: June 06, 2022
Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells.
Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells.
Journal: Biomedicines
Published: September 28, 2021
Diphenyleneiodonium efficiently inhibits the characteristics of a cancer stem cell model derived from induced pluripotent stem cells.
Journal: Cell biochemistry and function
Published: June 24, 2021
Effect of NADPH oxidase inhibitors in an experimental retinal model of excitotoxicity.
Journal: Experimental eye research
Published: May 09, 2020
A novel NADPH oxidase inhibitor targeting Nox4 in TGFβ-induced lens epithelial to mesenchymal transition.
Journal: Experimental eye research
Published: March 11, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026